Volume 24, Issue 5

Search all International Journal of Clinical Oncology articles

May 2019

18 articles in this issue

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan
Satoru Senoo
Kiichiro Ninomiya
Katsuyuki Kiura
Review Article 07 March 2019 Pages: 461 - 467
Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin
Satoshi Hamauchi
Tomoya Yokota
Akihiro Homma
Original Article 17 January 2019 Pages: 468 - 475
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy
Wei-Jing Gong
Li-Yun Ma
San-Lan Wu
OriginalPaper 28 January 2019 Pages: 476 - 484
Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC
Shunichi Sugawara
Kazuhiko Nakagawa
Tomohide Tamura
Original Article Open access 04 March 2019 Pages: 485 - 493
Interaction of H. pylori with toll-like receptor 2-196 to -174 ins/del polymorphism is associated with gastric cancer susceptibility in southern China
Jin Huang
Jun-Jie Hang
Xiao-Yong Wang
Original Article 15 December 2018 Pages: 494 - 500
Risk factors for cardiovascular mortality in patients with colorectal cancer: a population-based study
Apostolos Gaitanidis
Michail Spathakis
Michail Pitiakoudis
Original Article 02 January 2019 Pages: 501 - 507
Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer
Tomoyasu Yoshihiro
Hitoshi Kusaba
Eishi Baba
Original Article 02 January 2019 Pages: 508 - 515
mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival
Masamichi Yasuno
Hiroyuki Uetake
Kenichi Sugihara
Original Article Open access 05 January 2019 Pages: 516 - 525
External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model
Pawel Chrom
Jakub Zolnierek
Cezary Szczylik
Original Article 02 January 2019 Pages: 526 - 532
Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy
Yoshitaka Itami
Makito Miyake
Kiyohide Fujimoto
Original Article 02 January 2019 Pages: 533 - 545
Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
Keisuke Shigeta
Takeo Kosaka
Mototsugu Oya
Original Article 02 January 2019 Pages: 546 - 553
Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
Keisuke Shigeta
Takeo Kosaka
Mototsugu Oya
Correction 02 March 2019 Pages: 554 - 556
Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases
Hirotsugu Uemura
Hiroji Uemura
Nobuaki Matsubara
Original Article Open access 14 March 2019 Pages: 557 - 566
Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?
Kosuke Yoshida
Hiroaki Kajiyama
Fumitaka Kikkawa
Original Article 05 January 2019 Pages: 567 - 574
A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m² cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors
Fumiaki Isohashi
Tadao Takano
Takafumi Toita
Original Article Open access 22 December 2018 Pages: 575 - 582
Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study
Jinsoo Rhu
Chan Woo Cho
Sung Joo Kim
Original Article 02 January 2019 Pages: 583 - 589
c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia
Hiroyuki Kubo
Osamu Imataki
Norimitsu Kadowaki
Original Article 02 January 2019 Pages: 590 - 595
Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients
Satoko Ito
Haruyuki Ito
Kunihiko Ishitani
Original Article Open access 03 January 2019 Pages: 596 - 601

Volume 24, Issue 5

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin

STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy

Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

Interaction of H. pylori with toll-like receptor 2-196 to -174 ins/del polymorphism is associated with gastric cancer susceptibility in southern China

Risk factors for cardiovascular mortality in patients with colorectal cancer: a population-based study

Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer

mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model

Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy

Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration

Correction to: Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration

Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases

Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?

A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m² cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors

Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study

c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia

Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients

Navigation